Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review
Setor K. Kunutsor, Samuel Seidu
Topics & Concepts
MedicineTolerabilityDiscontinuationIntensive care medicineAdverse effectPharmacovigilanceClinical trialRandomized controlled trialNarrative reviewAcute kidney injuryObservational studyInternal medicineType 2 diabetesSystematic reviewDiabetes mellitusBioinformaticsPharmacologyType 2 Diabetes MellitusKidney diseasePatient safetyRisk assessmentPharmacotherapyPostmarketing surveillanceDiabetes Treatment and ManagementPancreatitis Pathology and TreatmentBariatric Surgery and Outcomes